Bain Capital Public Equity Management Ii, LLC Novartis Ag Transaction History

Bain Capital Public Equity Management Ii, LLC

$1.99 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $35.6 Million - $40.1 Million	-440,233 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $18.9 Million - $26.5 Million	-268,058 Reduced 37.85%	440,233 $36.3 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $36 Million - $40.7 Million	426,731 Added 151.56%	708,291 $67.1 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $60.2 Million - $66.3 Million	-703,194 Reduced 71.41%	281,560 $24.5 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $74.3 Million - $91.4 Million	984,754 New	984,754 $89.9 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account